A302-352A-T
- Brand
- Bethyl Laboratories
- Application
- IP
- Storage Conditions
- 2 - 8° C
- Host
- Rabbit
- Conjugation
- Unconjugated
- Immunogen
- between 503 and 553
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09% Sodium Azide
- Reactivity
- Human
- Target
- ASPL
- Shelf Life
- 1 year from date of receipt
- Antibody Type
- Polyclonal
- Alternate Names
- alveolar soft part sarcoma chromosomal region candidate gene 1 protein, alveolar soft part sarcoma chromosome region, candidate 1, alveolar soft part sarcoma locus, ASPCR1, ASPL, ASPS, RCC17, renal cell carcinoma gene on chromosome 17, renal cell carcinoma, papillary, 17, renal papillary cell carcinoma protein 17, tether containing UBX domain for GLUT4, TUG, UBX domain protein 9, UBX domain-containing protein 9, UBXD9, UBXN9
- Format
- Whole IgG
- Presumed Reactivity
- Based on 100% sequence identity, this antibody is predicted to react with Mouse
- Product Type
- Primary Antibodies
- Product Sub Types
- Primary Antibodies
- UNSPSC
- 12352203
- Western Blot (WB)
- Not recommended. A302-352A has not performed satisfactorily when used for WB of ASPL in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of ASPL.
- Immunoprecipitation (IP)
- 2 - 5 µg/mg lysate
- Target Sentence
- The gene which encodes ASPL (alveolar soft part sarcoma locus) has been identified as a fusion partner of the transcription factor TFE3 in ASPS and renal cell carcinomas.
- Product Link
- http://www.bethyl.com/product/A302-352A